Presentation is loading. Please wait.

Presentation is loading. Please wait.

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Published byAntoon Pieters Modified over 5 years ago

Similar presentations

Presentation on theme: "Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary."— Presentation transcript:

1 Relationship between selected metabolic parameters and the primary composite end point.
Relationship between selected metabolic parameters and the primary composite end point. A: Percentage of increased risk for the primary composite end point associated with elevated values of selected baseline metabolic factors. B–D: Hazard ratios by quartile of those selected metabolic parameters that were statistically significant: total cholesterol (tC) (B), LDL cholesterol (C), and triglycerides (TG) (D). *P < 0.05; **P < Gerald B. Appel et al. Dia Care 2003;26: ©2003 by American Diabetes Association

Download ppt "Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary."

Similar presentations

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:299-308.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
Trial profile Prakash Deedwania, et al. Lancet 2006; 368: 919-28.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:
Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8

Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
The effects of apo E alleles on various lipoprotein parameters

The effects of apo E alleles on various lipoprotein parameters
Dyslipidemia and the Risk of Developing Hypertension in a Working‐Age Male Population by Toshiaki Otsuka, Hirotaka Takada, Yasuhiro Nishiyama, Eitaro Kodani,

Dyslipidemia and the Risk of Developing Hypertension in a Working‐Age Male Population by Toshiaki Otsuka, Hirotaka Takada, Yasuhiro Nishiyama, Eitaro Kodani,
TNT: Baseline and final LDL cholesterol levels

TNT: Baseline and final LDL cholesterol levels
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.

A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.
Description of studies for pooled analyses

Description of studies for pooled analyses
Hazard ratios for the primary end point by subgroup of achieved LDL cholesterol (adjusted for age, sex, baseline calculated LDL cholesterol, diabetes,

Hazard ratios for the primary end point by subgroup of achieved LDL cholesterol (adjusted for age, sex, baseline calculated LDL cholesterol, diabetes,
Comparison of clinical and functional parameters among non-responders (=1) and responders (≥4) among healthy elderly and elderly patients with T2DM. Comparison.

Comparison of clinical and functional parameters among non-responders (=1) and responders (≥4) among healthy elderly and elderly patients with T2DM. Comparison.
Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,
Baseline Characteristics, Blood Pressures, and Laboratory Values

Baseline Characteristics, Blood Pressures, and Laboratory Values
Comparison of clinical and functional parameters between the CMV+ and CMV− participants in the healthy elderly and elderly patients with T2DM. Comparison.

Comparison of clinical and functional parameters between the CMV+ and CMV− participants in the healthy elderly and elderly patients with T2DM. Comparison.
Yearly trends in percentage of admissions for primary TB cases that occurred in selected high-risk groups from 1992 to 2011: secondary diagnoses of HIV.

Yearly trends in percentage of admissions for primary TB cases that occurred in selected high-risk groups from 1992 to 2011: secondary diagnoses of HIV.
Disposition of Patients in the Atherogenic Dyslipidemia Study

Disposition of Patients in the Atherogenic Dyslipidemia Study
(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.
Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.

Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.

Similar presentations

Ads by Google